Double-Blind Placebo-Controlled Randomized Study of Sporopollenin Exine (SpEC) Fragrance Encapsulation

Area of Science:

• Dermatology
• Cosmetic Science
• Materials Science

Background:

• Sporopollenin exine capsules (SpECs) are utilized for encapsulating pharmaceutical agents for oral delivery.
• The potential of SpECs for topical applications, specifically in fragrance delivery, remains largely unexplored.

Purpose of the Study:

• To investigate if fragrance encapsulated within SpECs enhances and prolongs perceived fragrance intensity compared to fragrance oil alone.
• To assess the in vitro cytotoxicity of SpECs and raw spores.

Main Methods:

• A double-blind, randomized pilot study involving ten healthy female participants comparing SpEC-encapsulated fragrance to fragrance oil.
• Fragrance intensity was measured using a visual analogue scale by participants and an independent reviewer over 8 hours.
• In vitro cytotoxicity was evaluated using an ATP viability assay on human bronchial epithelial cells.

Main Results:

• SpEC-encapsulated fragrance demonstrated significantly higher perceived intensity from 2 hours onwards compared to the control.
• Participant and reviewer assessments consistently showed prolonged fragrance perception with SpECs.
• In vitro testing revealed no cytotoxicity for SpECs, unlike raw spores which reduced cell viability.

Conclusions:

• Encapsulating fragrance within SpECs significantly prolongs its perceived intensity in topical applications.
• SpECs present a safe and effective sustained-release system for fragrance formulations.
• This technology holds promise for enhancing the longevity and user experience of topical fragrances.